These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5589168)

  • 1. [Utility of the diffusion test with carbon monoxide in functional exploration of the lung].
    Weber J; Moret P; Chauvet M
    Helv Med Acta; 1967; 34(1):Suppl:101-2. PubMed ID: 5589168
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of diffusion capacity for carbon monoxide in 2 groups of subjects with pulmonary tuberculosis and chronic obstructive bronchopathy].
    Lo Coco A
    G Ital Mal Torace; 1970; 24(1):27-30. PubMed ID: 5514979
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of functional respiratory exploration in the course of diffuse interstitial pulmonary fibrosis].
    Laval P; Feliciano JM; Kleisbauer JP; Poirier R
    Poumon Coeur; 1973; 29(5):597-602. PubMed ID: 4793540
    [No Abstract]   [Full Text] [Related]  

  • 4. The inelastic saclike component versus the slow time constant component of the distribution of ventilation by stage of respiratory dysfunction. Findings in patients.
    Brody AW; Blessum WT; Wagner JR; Weaver MJ
    Am Rev Respir Dis; 1970 Oct; 102(4):526-42. PubMed ID: 5456420
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology of the pulmonary circulation in chronic bronchopneumopathies].
    Turchetti A
    Atti Soc Ital Cardiol; 1964; 3():60-5. PubMed ID: 5861829
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary function in bronchial asthma.
    Meisner P; Hugh-Jones P
    Br Med J; 1968 Feb; 1(5590):470-5. PubMed ID: 5643718
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pulmonary diffusion capacity for carbon monoxide studied with the rebreathing method. II. Results in patients with chronic bronchitis, bronchial asthma and pulmonary emphysema].
    CAPODAGLIO E; PEZZAGNO G; RIZZO A
    G Clin Med; 1961 Jun; 42():639-53. PubMed ID: 13690583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Functional respiratory investigations. Ductance of CO (carbon monoxide): global estimation of pulmonary exchanger, omitting blood tests].
    Lacoste J
    Presse Med (1893); 1971 Oct; 79(41):1781-4. PubMed ID: 5119026
    [No Abstract]   [Full Text] [Related]  

  • 9. [Functional and morphological correlation in chronic obstructive pulmonary diseases].
    Figueroa Casas JC; Greenberg SD; Jenkins DE
    Medicina (B Aires); 1968; 28(4):171-8. PubMed ID: 5746835
    [No Abstract]   [Full Text] [Related]  

  • 10. Ventilatory effect of decreasing functional residual capacity in pulmonary emphysema.
    Barach AL; Chusid EL; Wood L
    Ann Allergy; 1967 Apr; 25(4):211-23. PubMed ID: 6022290
    [No Abstract]   [Full Text] [Related]  

  • 11. [Lung function parameters in the follow-up of fibrotic lung diseases].
    Siemon G
    Prax Klin Pneumol; 1983 Sep; 37(9):358-63. PubMed ID: 6634637
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic significance of chronic bronchitis in the development of reversible and irreversible chronic airflow limitation.
    Nugent K
    Semin Respir Infect; 1994 Mar; 9(1):3-7. PubMed ID: 7973164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness of the carbon monoxide diffusion test in examinations of the lung function].
    Weber J; Moret P; Chauvet M
    Helv Med Acta Suppl; 1967 May; 47():101-2. PubMed ID: 5286282
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies of respiratory drive and respiratory response in normal persons and in patients with emphysema, asthma and lung fibrosis].
    Scheidt-Mackes M; Kesseler KH; Magnussen H
    Prax Klin Pneumol; 1983 Oct; 37 Suppl 1():819-22. PubMed ID: 6417643
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between maximum inspiratory pressure and total lung capcaity (coefficient of retraction) in normal patients and in patients with emphysema, asthma, and diffuse pulmonary infiltration.
    Schlueter DP; Immekus J; Stead WW
    Aspen Emphysema Conf; 1968; 9():267-83. PubMed ID: 5722663
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfer factor for carbon monoxide in patients with airways obstruction.
    Bedell GN; Ostiguy GL
    Clin Sci; 1967 Apr; 32(2):239-48. PubMed ID: 6022818
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbon monoxide and exercise tolerance in chronic bronchitis and emphysema.
    Calverley PM; Leggett RJ; Flenley DC
    Br Med J (Clin Res Ed); 1981 Oct; 283(6296):878-80. PubMed ID: 6793157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Disorders of distribution of ventilation in silicotic pulmonary fibrosis].
    Navrátil M
    Z Tuberk Erkr Thoraxorg; 1966; 125(3):267-71. PubMed ID: 6014532
    [No Abstract]   [Full Text] [Related]  

  • 19. [The CO diffusion capacity in chronic bronchitis].
    Vanroux R; Gregoire M
    Acta Tuberc Pneumol Belg; 1964; 55(6):488-97. PubMed ID: 5825375
    [No Abstract]   [Full Text] [Related]  

  • 20. THE RELATIONSHIPS BETWEEN MINUTE VENTILATION, PULMONARY GAS DIFFUSION AND RESPIRATORY WORK MEASURED SIMULTANEOUSLY DURING A STANDARD EXERCISE TEST.
    WOOLF CR
    Dis Chest; 1965 Jun; 47():616-26. PubMed ID: 14292940
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.